Evaluation of the stability of the Caesalpinia spinosa extract under stress-induced conditions.
DOI:
https://doi.org/10.3407/rpn.v5i2.6891Keywords:
P2Et, Caesalpinia spinosa, stability, degradation, induced stressAbstract
An extract obtained from Caesalpinia Spinosa, has been investigated for several years on the PUJ, because of its therapeutic potential against breast cancer.
References
. Aguilar-Gálvez, A., Noratto, G., Chambi, F., Debaste, F., Campos, D. (2014). Potential of tara (Caesalpinia spinosa) gallotannins and hydrolysates as natural antibacterial compounds. Food chemistry. 156: 301-304.
. Ballesteros-Ramírez, R., Durán, M. I., & Fiorentino, S. (2021). Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from Caesalpinia spinosa. Toxicology Reports, 8(43), 258–263. https://doi.org/10.1016/j.toxrep.2020.12.024
. Dávalos, J. Z., Romero, V. L., Sánchez, J. I., Chávez, J., & Valderrama-Negrón, A. (2017). Caracterización, mediante espectrometría de masas de alta resolución maldi/fticr, de taninos hidrolizables de la tara (Caesalpinia spinosa). (Spanish). Revista de La Sociedad Química Del Perú, 83(1), 106–114.
. De la Cruz, P. (2004). Aprovechamiento Integral y Racional de la Tara. Caesalpinia spinosa - Caesalpinia tinctoria. An Integral and Rational Utility of Tara (Caesalpinia spinosa – Caesalpinia tinctoria). Revista Del Instituto de Investigación FIGMMG, 7, 64–73. https://revistasinvestigacion.unmsm.edu.pe/index.php/iigeo/article/view/733
. Fiorentino, S., & Urueña, C. (2018). La fitoterapia como fuente de medicamentos reguladores del metabolismo tumoral y activadores de la respuesta inmunitaria. Revista de La Academia Colombiana de Ciencias Exactas, Físicas y Naturales, 42(163), 132. https://doi.org/10.18257/raccefyn.542
. Francisco J. Higuera Ramírez. (2005). Estabilidad de Medicamentos. Norma Oficial Mexicana, 1–72. http://www.salud.gob.mx/unidades/cdi/nom/073ssa13.html
. Invima. (2005). Validación de Métodos Analíticos. Buenas Prácticas Para Laboratorios Nacionales de Control Farmacéutico Anexo 3 Informe 36, 1–30. 43 http://new.paho.org/hq/dmdocuments/2008/13_Modulo_VALIDACIoN_de_Metodos_ Fisicoqcos.pdf
. Invima. (2015). Guía Para La Presentación De Estudios De Estabilidad De Medicamentos En Investigación. 7. https://www.invima.gov.co/images/stories/formatotramite/PM01-RS-G61.pdf
. Invima (2022). Registro sanitario de preparaciones farmacéuticas con base en plantas medicinales y productos fitoterapéuticos tradicionales de fabricación nacional. http://visor.suit.gov.co/VisorSUIT/index.jsf?FI=884
. Machado, M., Mahy, T., Pérez, E., Noroña, M., Fajardo, E. M., & Izquierdo, L. (2007). Estudios de estabilidad de vida de estante en condiciones de estrés de la vacuna antileptospirósica vax-SPIRAL. Revista VacciMonitor (Vacunología y Temas Afines), 16(1), 1–4.
. Niazi, S. K. (2020). Stability Testing of New Drug Substances and Products. Handbook of Pharmaceutical Manufacturing Formulations, February, 31–40. https://doi.org/10.1201/9781420048452-7
. Sandoval Medina, T. A., & Fiorentino Gómez, S. (2016). Evaluación de la actividad antitumoral de la fracción P2Et obtenida de Caesalpinia spinosa y los compuestos aislados de la misma, en el control de las células madre tumorales en un modelo de cáncer de seno metastásSandoval, T. A., Urueña, C. P., Llano, M., Gómez-Cadena, A., Hernández, J. F., Sequeda, L. G., Fiorentino, S. (2016). Standardized Extract from Caesalpinia spinosa is Cytotoxic Over Cancer Stem Cells and Enhance Anticancer Activity of Doxorubicin. The American Journal of Chinese Medicine. (08): 1693-1717.
. Singh, S. y Bakshi, M. (2000). Orientación sobre la realización de pruebas de estrés para determinar la estabilidad inherente de los fármacos
Downloads
Published
Issue
Section
Categories
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
License Terms
The Creative Commons Attribution License (CC BY 4.0) allows users to copy, distribute and transmit an article and adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
- You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
- No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity.